Find Triptorelin Pamoate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

API REF. PRICE (USD/KG)

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 57773-63-4, Triptoreline, Arvekap, (d-trp6)-gnrh, Decapeptyl, Triptorelina
Molecular Formula
C64H82N18O13
Molecular Weight
1311.4  g/mol
InChI Key
VXKHXGOKWPXYNA-PGBVPBMZSA-N

Triptorelin Pamoate
A potent synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE with D-tryptophan substitution at residue 6.
1 2D Structure

Triptorelin Pamoate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
2.1.2 InChI
InChI=1S/C64H82N18O13/c1-34(2)23-46(56(88)75-45(13-7-21-69-64(66)67)63(95)82-22-8-14-52(82)62(94)72-31-53(65)85)76-58(90)48(25-36-28-70-42-11-5-3-9-40(36)42)78-57(89)47(24-35-15-17-39(84)18-16-35)77-61(93)51(32-83)81-59(91)49(26-37-29-71-43-12-6-4-10-41(37)43)79-60(92)50(27-38-30-68-33-73-38)80-55(87)44-19-20-54(86)74-44/h3-6,9-12,15-18,28-30,33-34,44-52,70-71,83-84H,7-8,13-14,19-27,31-32H2,1-2H3,(H2,65,85)(H,68,73)(H,72,94)(H,74,86)(H,75,88)(H,76,90)(H,77,93)(H,78,89)(H,79,92)(H,80,87)(H,81,91)(H4,66,67,69)/t44-,45-,46-,47-,48+,49-,50-,51-,52-/m0/s1
2.1.3 InChI Key
VXKHXGOKWPXYNA-PGBVPBMZSA-N
2.1.4 Canonical SMILES
CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8
2.1.5 Isomeric SMILES
CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8
2.2 Synonyms
2.2.1 MeSH Synonyms

1. 6-d-tryptophan-luteinizing Hormone-releasing Factor (pig)

2. Ay 25650

3. Ay-25650

4. Ay25650

5. Cl 118532

6. Cl-118532

7. Cl118532

8. D-trp-6-lh-rh

9. Decapeptyl

10. Decapeptyl Depot

11. Decapeptyl Lp

12. Decapeptyl Trimestral

13. Embonate, Triptorelin

14. Gnrh, Trp(6)-

15. Lhrh, Trp(6)-

16. Lhrh, Tryptophyl(6)-

17. Pamoate, Triptorelin

18. Trelstar

19. Trimestral, Decapeptyl

20. Triptorelin Embonate

21. Triptorelin Pamoate

22. Wy 42462

23. Wy-42462

24. Wy42462

2.2.2 Depositor-Supplied Synonyms

1. 57773-63-4

2. Triptoreline

3. Arvekap

4. (d-trp6)-gnrh

5. Decapeptyl

6. Triptorelina

7. Triptorelinum

8. Trelstar

9. Triptodur

10. Diphereline

11. (6-d-tryptophan)luteinizing Hormone-releasing Hormone

12. Cl 118532

13. Cl-118532

14. Pglu-his-trp-ser-tyr-d-trp-leu-arg-pro-gly-nh2

15. Ay-25650

16. Luteinizing Hormone-releasing Factor (pig), 6-d-tryptophan

17. Cl 118,532

18. Chebi:63633

19. Wy 42462

20. Ay 25650

21. Pamorelin

22. Salvacyl

23. Trelstar Depot

24. 5-oxo-l-prolyl-l-histidyl-l-tryptophyl-l-seryl-l-tyrosyl-d-tryptophyl-l-leucyl-l-arginyl-l-prolylglycinamide

25. Trelstar La

26. Luteinizing Hormone-releasing Factor (swine), 6-d-tryptophan-

27. Bim 21003

28. Wy 42422

29. Tryptorelin

30. Diferelin

31. D-tryptophan-lh-rh

32. Triptoreline [inn-french]

33. Triptorelinum [inn-latin]

34. Triptorelina [inn-spanish]

35. Trellasar

36. Moapar

37. Triptorelin [usan:inn:ban]

38. Decapeptyl Sr

39. Pamorelin La

40. Unii-9081y98w2v

41. Triptorelin (swine)

42. Wy-42462

43. D-trp6-lhrh

44. Debio-8206

45. Triptorelin (usan/inn)

46. (d-trp6)-lh-rh

47. Gtpl1177

48. Schembl5079698

49. Chembl1201334

50. Dtxsid2048375

51. Schembl22289009

52. Hms2090c17

53. Ex-a3857

54. Bim-21003

55. Akos030213249

56. 9081y98w2v

57. Cs-5745

58. Db06825

59. Ncgc00167301-01

60. Ncgc00167301-02

61. As-71149

62. Bn-52014

63. Hy-12551

64. 73t634

65. C75704

66. D06247

67. [d-trp6]-lh-rh, >=97% (hplc), Powder

68. Ab01275488-01

69. A936467

70. Pglu-his-trp-ser-tyr-d-trp-leu-arg-pro-glynh2

71. Q1992452

72. (s)-1-((3s,6s,9s,12s,15r,18s,21s)-3-((1h-imidazol-5-yl)methyl)-6,15-bis((1h-indol-3-yl)methyl)-21-(3-guanidinopropyl)-12-(4-hydroxybenzyl)-9-(hydroxymethyl)-18-isobutyl-1,4,7,10,13,16,19-heptaoxo-1-((s)-5-oxopyrrolidin-2-yl)-2,5,8,11,14,17,20-heptaazadocosan-22-oyl)-n-(2-amino-2-oxoethyl)pyrrolidine-2-carboxamide

73. Glycinamide, 5-oxo-l-prolyl-l-histidyl-l-tryptophyl-l-seryl-l-tyrosyl-d-tryptophyl-l-leucyl-l-arginyl-l-prolyl-

2.3 Create Date
2008-12-10
3 Chemical and Physical Properties
Molecular Weight 1311.4 g/mol
Molecular Formula C64H82N18O13
XLogP3-0.3
Hydrogen Bond Donor Count17
Hydrogen Bond Acceptor Count15
Rotatable Bond Count33
Exact Mass1310.63087474 g/mol
Monoisotopic Mass1310.63087474 g/mol
Topological Polar Surface Area490 Ų
Heavy Atom Count95
Formal Charge0
Complexity2710
Isotope Atom Count0
Defined Atom Stereocenter Count9
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameTrelstar
PubMed HealthTriptorelin (Injection)
Drug ClassesAntineoplastic Agent, Endocrine-Metabolic Agent
Drug LabelTRELSTAR is a white to slightly yellow lyophilized cake. When reconstituted, TRELSTAR has a milky appearance. It contains a pamoate salt of triptorelin, a synthetic decapeptide agonist analog of gonadotropin releasing hormone (GnRH). The chemical...
Active IngredientTriptorelin pamoate
Dosage FormInjectable
RouteIntramuscular
Strengtheq 11.25mg base/vial; eq 3.75mg base/vial; eq 22.5mg base/vial
Market StatusPrescription
CompanyWatson Labs

2 of 2  
Drug NameTrelstar
PubMed HealthTriptorelin (Injection)
Drug ClassesAntineoplastic Agent, Endocrine-Metabolic Agent
Drug LabelTRELSTAR is a white to slightly yellow lyophilized cake. When reconstituted, TRELSTAR has a milky appearance. It contains a pamoate salt of triptorelin, a synthetic decapeptide agonist analog of gonadotropin releasing hormone (GnRH). The chemical...
Active IngredientTriptorelin pamoate
Dosage FormInjectable
RouteIntramuscular
Strengtheq 11.25mg base/vial; eq 3.75mg base/vial; eq 22.5mg base/vial
Market StatusPrescription
CompanyWatson Labs

4.2 Drug Indication

Triptorelin is indicated for the palliative treatment of advanced prostate cancer.


FDA Label


For the synchronisation of ovulation in weaned sows to enable a single fixed-time artificial insemination.


5 Pharmacology and Biochemistry
5.1 Pharmacology

The first administration of triptorelin is followed by a transient surge of follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol,and testosterone. The time, peak and decline of testosterone in the body varies depending on the dose administered. This initial surge is often responsible for worsening of prostate cancer symptoms such as urethral or bladder outlet obstruction, bone pain, spinal cord injury and hematuria in the early stages. A sustained decrease in FSH and LH, and significant reduction of testicular steroidogenesis is usually seen 2-4 weeks post-initiation of therapy. This result is a reduction of serum testosterone to levels which are typically seen in surgically castrated men. Ultimately, tissues and functions that require these hormones become inactive. The effects of triptorelin can usually be reversed once the drug is discontinued.


5.2 MeSH Pharmacological Classification

Antineoplastic Agents, Hormonal

Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)


Luteolytic Agents

Chemical compounds that cause LUTEOLYSIS or degeneration of the CORPUS LUTEUM. (See all compounds classified as Luteolytic Agents.)


5.3 ATC Code

QH01CA97


L - Antineoplastic and immunomodulating agents

L02 - Endocrine therapy

L02A - Hormones and related agents

L02AE - Gonadotropin releasing hormone analogues

L02AE04 - Triptorelin


5.4 Absorption, Distribution and Excretion

Absorption

Following IV administration of triptorelin, triptorelin is completely absorbed.


Route of Elimination

Elimination of triptorelin involves both the kidneys and the liver.


Volume of Distribution

After a single IV dose of 0.5mg, the volume of distribution of triptorelin peptide in healthy males was 30 - 33L.


Clearance

In healthy male volunteers, total clearance of triptorelin was 211.9 mL/min.


5.5 Metabolism/Metabolites

The metabolism of triptorelin in humans is not well understood; however, metabolism likely does not involve hepatic enzymes such as cytochrome P450. Whether or not triptorelin affects, or how it affects other metabolizing enzymes is also poorly understood. Triptorelin has no identified metabolites.


5.6 Biological Half-Life

The pharmacokinetics of triptorelin follows a 3 compartment model. The half lives are estimated to be 6 minutes, 45 minutes, and 3 hours respectively.


5.7 Mechanism of Action

Triptorelin is a synthetic agonist analog of gonadotropin releasing hormone (GnRH). Animal studies comparing triptorelin to native GnRH found that triptorelin had 13 fold higher releasing activity for luteinizing hormone, and 21-fold higher releasing activity for follicle-stimulating hormone.


API SUPPLIERS

read-more
read-more

01

Bachem AG

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Bachem company banner

02

Omgene Life Sciences Pvt. Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Omgene Company Banner

03

Sumar Biotech

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSumar Biotech work together to Innovate & Manufacture Semi-synthetic, Synthetic & Fermentation API.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Sumar Biotech

04

Debiopharm

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Debiopharm

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

05

Hainan Shuangcheng Pharmaceuticals

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Hainan Shuangcheng Pharmaceuticals

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

06

Chinese Peptide Company

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

07

Apicore

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Apicore

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

BCN Peptides

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

09

PolyPeptide Group

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

PolyPeptide Group

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF CEP/COS JDMF EU-WCInactive-api NDC KDMF VMF Others AUDIT
blank

10

Teva Pharmaceutical Industries

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

Bachem Ag

Switzerland
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 6291

Submission : 1986-04-25

Status : Active

Type : II

Bachem company banner

02

Pharmex
Not Confirmed

02

Pharmex
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 30364

Submission : 2016-03-11

Status : Active

Type : II

blank

03

Pharmex
Not Confirmed
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

PolyPeptide Group

Switzerland
Pharmex
Not Confirmed
arrow

PolyPeptide Group

Switzerland
arrow
Pharmex
Not Confirmed

Triptorelin IH

Date of Issue : 2022-08-02

Valid Till : 2025-06-27

Written Confirmation Number : WC-0047

Address of the Firm : Plot No. K-28, Additional MIDC, Anandnagar, Ambernath- 421506, Dist- Thane, Maha...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

Bachem AG

Switzerland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content

TRIPTORELIN PAMOATE

NDC Package Code : 55463-0006

Start Marketing Date : 2006-06-21

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

Bachem company banner

02

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

TRIPTORELIN PAMOATE

NDC Package Code : 62788-715

Start Marketing Date : 2000-06-15

End Marketing Date : 2025-12-31

Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (3.75mg/2mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

03

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

TRIPTORELIN PAMOATE

NDC Package Code : 62788-437

Start Marketing Date : 2010-10-03

End Marketing Date : 2025-12-31

Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (22.5mg/2mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

04

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

TRIPTORELIN PAMOATE

NDC Package Code : 62788-956

Start Marketing Date : 2017-06-29

End Marketing Date : 2025-12-31

Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (22.5mg/2mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

05

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

TRIPTORELIN PAMOATE

NDC Package Code : 62788-288

Start Marketing Date : 2001-06-29

End Marketing Date : 2025-12-31

Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (11.25mg/2mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

06

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

TRIPTORELIN PAMOATE

NDC Package Code : 71161-105

Start Marketing Date : 2010-03-11

End Marketing Date : 2025-12-31

Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (22.5mg/2mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

07

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

TRIPTORELIN

NDC Package Code : 71161-106

Start Marketing Date : 2017-09-08

End Marketing Date : 2025-12-31

Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (22.5mg/2mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

08

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

TRIPTORELIN PAMOATE

NDC Package Code : 71161-104

Start Marketing Date : 2001-06-29

End Marketing Date : 2025-12-31

Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (11.25mg/2mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

09

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

TRIPTORELIN PAMOATE

NDC Package Code : 71161-103

Start Marketing Date : 2000-06-15

End Marketing Date : 2025-12-31

Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (3.75mg/2mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Bachem AG

Switzerland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content

Triptorelin Pamoate

About the Company : With more than 50 years of experience and expertise, Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology comp...

With more than 50 years of experience and expertise, Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide, providing a wide range of services. Over the years, Bachem has established itself as a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company is headquartered in Switzerland and has offices in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.
Bachem company banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Flag India
Digital Content Digital Content

Triptorelin Pamoate

About the Company : Omgene Life Sciences Private Limited is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives. As a vertically...

Omgene Life Sciences Private Limited is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives. As a vertically integrated company, we focus on developing high-quality formulations based on in-house-produced actives. With GMP-certified facilities and partnerships with contract manufacturers, we excel in formulation development for injectables, lyophilized injectables, complex generics, and oral peptide delivery systems, ensuring affordable, top-quality medicines.
Omgene Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSumar Biotech work together to Innovate & Manufacture Semi-synthetic, Synthetic & Fermentation API.

Flag India
Digital Content Digital Content

Triptorelin Pamoate

About the Company : Sumar Biotech LLP, registered in January 2018, is a startup approved by the Gujarat State Biotechnology Mission. It was founded by emerging entrepreneurs and a team of young yet ex...

Sumar Biotech LLP, registered in January 2018, is a startup approved by the Gujarat State Biotechnology Mission. It was founded by emerging entrepreneurs and a team of young yet experienced research scientists and manufacturing professionals. We work together to innovate and manufacture semi-synthetic, synthetic, and fermentation-based APIs. Our R&D facility is equipped with state-of-the-art technology for synthesis, extraction, isolation, and purification of products from the upstream (fermentation) process. Our team is also involved in developing and implementing new ideas in process chemistry for various therapeutic molecules.
Sumar Biotech

04

Apicore

India
EPS
Not Confirmed
arrow

Apicore

India
arrow
EPS
Not Confirmed

Triptorelin Pamoate

About the Company : Apicore LLC, a wholly owned subsidiary of RK Pharma Inc is a leading process R&D and API manufacturing service provider for the worldwide pharmaceutical industry. We offer a wide p...

Apicore LLC, a wholly owned subsidiary of RK Pharma Inc is a leading process R&D and API manufacturing service provider for the worldwide pharmaceutical industry. We offer a wide portfolio of services ranging from API’s for the generic industry to custom synthesis for early phase pharmaceutical research and branded products. Our USFDA approved facilities in India (Visakhapatnam, Andhra Pradesh and Vadodara, Gujarat) are both equipped with state-of-the-art analytical and research capabilities. While our worldwide network of locations seamlessly integrate with each other, each unit also independently houses a full
blank

05

BCN Peptides

Spain
EPS
Not Confirmed
arrow

BCN Peptides

Spain
arrow
EPS
Not Confirmed

Triptorelin

About the Company : BCN Peptides is a privately own company completely focused on the cGMP manufacture of Bioactive Peptides for Pharmaceutical and Veterinary applications. We are a customer oriented...

BCN Peptides is a privately own company completely focused on the cGMP manufacture of Bioactive Peptides for Pharmaceutical and Veterinary applications. We are a customer oriented organization focused on fulfilling the client’s needs at each stage of the their peptide drug development and lifecycle management. It also includes a team of dedicated and passionate scientists which help us to provide to our customer a scientific excellence in terms of synthetic peptide chemistry and analytical expertise. BCN Peptides has an excellent track record of successful inspections by Global Health Agencies (US FDA, EDQM, KFDA,…)
blank

06

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Triptorelin

About the Company : CPC is a peptide and Oligonucleotide focused manufacturer founded in 2001 with both facilities in China and US. We are strong at CDMO and CRO for peptide APIs and have proved track...

CPC is a peptide and Oligonucleotide focused manufacturer founded in 2001 with both facilities in China and US. We are strong at CDMO and CRO for peptide APIs and have proved track record with lot of big Pharm companies and Biotech companies in US, Europe and Asia. We have a full spectrum of peptide products and services from discovery to commercialization, from mg to Kg, from non-GMP to GMP. We are the first US FDA and EMA GMP inspected peptide professional supplier in Asia. Our key competitive edge is large scale GMP manufacturing for clinical and commercial projects. And we also have rich experience in neoantigen peptide projects.
blank

07

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Triptorelin

About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...

Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Excipients, Herbal extracts, Formulation of Chinese & Western Medicine. With abundant economic strength, the group has successfully developed to a pharmaceutical group enterprise wich intergrets operation of medicine & related products, processing & manufacturing, and importation & exportation together.
blank

08

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Triptorelin

About the Company : JIN DUN Medical Research Institute is affiliated to Shanghai JIN DUN Industrial Co., Ltd., headquartered in Shanghai, adjacent to Hongqiao High-speed Railway Station and Hongqiao I...

JIN DUN Medical Research Institute is affiliated to Shanghai JIN DUN Industrial Co., Ltd., headquartered in Shanghai, adjacent to Hongqiao High-speed Railway Station and Hongqiao International airport. JIN DUN Medical Research Institute is committed to providing pharmaceutical intermediates and raw materials with the purpose of innovative drug research. Customized R&D and customized production services.
blank

09

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Triptorelin

About the Company : Smaart Pharmaceutticals consciously strive for innovation through newer technologies, modern equipment available betterment of life and bring newer products for its customer. Smaa...

Smaart Pharmaceutticals consciously strive for innovation through newer technologies, modern equipment available betterment of life and bring newer products for its customer. Smaart has two state of the art manufacturing blocks. Our registered office is located at Jalgaon; which is our manufacturing facility as well. Geographically Jalgaon falls at North of Maharashtra, in the close vicinity of The famous ancient Buddhist cave temples of Ajanta; which were excavated between the 2d century BC and the 5th century AD.
blank

10

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Triptorelin

About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and...

Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1737052200,"product":"PHARMACEUTICAL API: TRIPTORELIN ACETATEPOWDER (SYNTHETIC)","address":"D-68, AMBABARI","city":"JAIPUR, RAJASTHAN","supplier":"ELCON DRUGS AND FORMULATIONS LTD","supplierCountry":"INDIA","foreign_port":"MOSCOW","customer":"JSC PHARMASYNTEZ","customerCountry":"RUSSIA","quantity":"0.21","actualQuantity":"205","unit":"GMS","unitRateFc":"37751.5","totalValueFC":"89747.5","currency":"USD","unitRateINR":37750.524390243903,"date":"17-Jan-2025","totalValueINR":"7738857.5","totalValueInUsd":"89747.5","indian_port":"Bombay Air","hs_no":"29371900","bill_no":"7370789","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"D-68, AMBABARI, JAIPUR, RAJASTHAN","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703269800,"product":"TRIPTORELIN PAMOATE","address":"101, SITARAM MANSION,","city":"KAROL BAGH, NEW DELHI","supplier":"SHENZHEN JYMED TECHNOLOGY CO LTD","supplierCountry":"CHINA","foreign_port":"GUANGZHOU","customer":"JODAS EXPOIM PRIVATE LTD","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"0.03","unit":"KGS","unitRateFc":"350000","totalValueFC":"10570.2","currency":"USD","unitRateINR":"29330000","date":"23-Dec-2023","totalValueINR":"879900","totalValueInUsd":"10570.2","indian_port":"Hyderabad Air","hs_no":"29371900","bill_no":"9372624","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"GUANGZHOU","supplierAddress":"RM 806-810 1# 8\/F BIOMEDICINE INNOVATION INDUSTRIAL PARKSDNF China","customerAddress":"101, SITARAM MANSION,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705602600,"product":"TRIPTORELIN ACETATE ( 25G)","address":"101, SITARAM MANSION,","city":"KAROL BAGH, NEW DELHI","supplier":"CHINESE PEPTIDE CO LTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"JODAS EXPOIM PRIVATE LTD","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"0.025","unit":"KGS","unitRateFc":"470000","totalValueFC":"11889.7","currency":"USD","unitRateINR":"39527000","date":"19-Jan-2024","totalValueINR":"988175","totalValueInUsd":"11889.7","indian_port":"Hyderabad Air","hs_no":"29371900","bill_no":"9728108","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"NO.69 12TH STREET HANGZHOU ECONOMIC& TECHNOLOGICAL DEVELOPMENT ZONESDNF China","customerAddress":"101, SITARAM MANSION,"}]
23-Dec-2023
17-Jan-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more

Details:

Debiopharm to enter into this new alliance with Aspen, a well-established and trusted pharmaceutical partner for the commercialization of Trelstar® in South Africa and recognize the therapeutic benefits that Trelstar® could bring to prostate cancer patients in this region.


Lead Product(s): Triptorelin Pamoate

Therapeutic Area: Oncology Brand Name: Trelstar

Study Phase: Approved FDFProduct Type: Hormone

Sponsor: Debiopharm

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership January 02, 2022

Aspen API Comapny Banner

01

Details : Debiopharm to enter into this new alliance with Aspen, a well-established and trusted pharmaceutical partner for the commercialization of Trelstar® in South Africa and recognize the therapeutic benefits that Trelstar® could bring to prostate cancer pat...

Product Name : Trelstar

Product Type : Hormone

Upfront Cash : Undisclosed

January 02, 2022

Aspen API Comapny Banner

Details:

Debio 4326 is a unique injectable, biodegradable 12-month extended-release formulation of triptorelin, being developed for pediatric participants for central precocious puberty.


Lead Product(s): Triptorelin Pamoate

Therapeutic Area: Endocrinology Brand Name: Trelstar

Study Phase: Phase IIIProduct Type: Hormone

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 09, 2024

blank

02

Debiopharm

Switzerland
arrow
EPS
Not Confirmed

Debiopharm

Switzerland
arrow
EPS
Not Confirmed

Details : Debio 4326 is a unique injectable, biodegradable 12-month extended-release formulation of triptorelin, being developed for pediatric participants for central precocious puberty.

Product Name : Trelstar

Product Type : Hormone

Upfront Cash : Inapplicable

September 09, 2024

blank

Details:

The net proceeds will be allocated to advancing the company’s pipeline, including FP-014 (triptorelin), a ready-to-use, long-acting injectable developed for the treatment of prostate cancer.


Lead Product(s): Triptorelin Pamoate

Therapeutic Area: Oncology Brand Name: FP-014

Study Phase: Phase IIProduct Type: Hormone

Sponsor: Undisclosed

Deal Size: $42.1 million Upfront Cash: Undisclosed

Deal Type: Financing April 12, 2024

blank

03

EPS
Not Confirmed
EPS
Not Confirmed

Details : The net proceeds will be allocated to advancing the company’s pipeline, including FP-014 (triptorelin), a ready-to-use, long-acting injectable developed for the treatment of prostate cancer.

Product Name : FP-014

Product Type : Hormone

Upfront Cash : Undisclosed

April 12, 2024

blank

Details:

Dexa Medica’s nation-wide launch and distribution of triptorelin, as Debiopharm’s exclusive Indonesian licensee, will help patients in the region gain access to the pain-relieving benefits of hormone suppression with Pamorelin®.


Lead Product(s): Triptorelin Pamoate

Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Pamorelin

Study Phase: Approved FDFProduct Type: Hormone

Sponsor: Debiopharm

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration July 10, 2021

blank

04

Dexa Medica

Indonesia
arrow
EPS
Not Confirmed

Dexa Medica

Indonesia
arrow
EPS
Not Confirmed

Details : Dexa Medica’s nation-wide launch and distribution of triptorelin, as Debiopharm’s exclusive Indonesian licensee, will help patients in the region gain access to the pain-relieving benefits of hormone suppression with Pamorelin®.

Product Name : Pamorelin

Product Type : Hormone

Upfront Cash : Undisclosed

July 10, 2021

blank

Details:

The companies have entered into an exclusive agreement that grants Verity Pharmaceuticals Inc. the rights to commercialize Trelstar® (triptorelin pamoate for injectable suspension), a hormone therapy for patients living with prostate cancer.


Lead Product(s): Triptorelin Pamoate

Therapeutic Area: Oncology Brand Name: Trelstar

Study Phase: Approved FDFProduct Type: Hormone

Sponsor: Verity Pharmaceuticals Inc

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement September 06, 2020

blank

05

Debiopharm

Switzerland
arrow
EPS
Not Confirmed

Debiopharm

Switzerland
arrow
EPS
Not Confirmed

Details : The companies have entered into an exclusive agreement that grants Verity Pharmaceuticals Inc. the rights to commercialize Trelstar® (triptorelin pamoate for injectable suspension), a hormone therapy for patients living with prostate cancer.

Product Name : Trelstar

Product Type : Hormone

Upfront Cash : Undisclosed

September 06, 2020

blank

Details:

The agreement grants Knight the rights to commercialize Trelstar® (triptorelin) in Canada.


Lead Product(s): Triptorelin Pamoate

Therapeutic Area: Oncology Brand Name: Trelstar

Study Phase: Approved FDFProduct Type: Hormone

Sponsor: Knight Therapeutics

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership August 01, 2020

blank

06

Debiopharm

Switzerland
arrow
EPS
Not Confirmed

Debiopharm

Switzerland
arrow
EPS
Not Confirmed

Details : The agreement grants Knight the rights to commercialize Trelstar® (triptorelin) in Canada.

Product Name : Trelstar

Product Type : Hormone

Upfront Cash : Undisclosed

August 01, 2020

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Triptorelin

Brand Name : Trelstar LA 3,75 mg

Dosage Form : POI

Dosage Strength : 3.75mg

Packaging : 2X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

02

Triptorelin

Brand Name : Trelstar LA 11,25 mg

Dosage Form : POI

Dosage Strength : 11.25mg

Packaging : 2X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

03

Triptorelin

Brand Name : Trelstar LA 22,5 mg

Dosage Form : POI

Dosage Strength : 22.5mg

Packaging : 2X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

04

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

TRIPTORELIN PAMOATE

Brand Name : TRIPTODUR KIT

Dosage Form : FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

Dosage Strength : EQ 22.5MG BASE/VIAL

Packaging :

Approval Date : 2017-06-29

Application Number : 208956

Regulatory Info : RX

Registration Country : USA

blank

05

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Triptorelin

Brand Name : Gonapeptyl Depot

Dosage Form : Tryptoreline 3,75Mg 1 Unit Parenteral Use

Dosage Strength : 1 syringe IM SC 3.75 mg + 1 ampoule solv 1 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Triptorelini acetas hydricus

Brand Name : Decapeptyl

Dosage Form : Inj L?s

Dosage Strength : 0.1mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

07

Ipsen

France
EPS
Not Confirmed
arrow

Ipsen

France
arrow
EPS
Not Confirmed

Triptorelin

Brand Name : Decapeptyl

Dosage Form :

Dosage Strength : 7 Vials 0.1 Mg + 7 Vials Solv  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

Ipsen

France
EPS
Not Confirmed
arrow

Ipsen

France
arrow
EPS
Not Confirmed

Triptorelin

Brand Name : Diphereline

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

09

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Triptorelin

Brand Name : Microrelin

Dosage Form : Injection

Dosage Strength : 3.75MG/2ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Iran

blank

10

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

TRIPTORELIN PAMOATE

Brand Name : TRELSTAR

Dosage Form : INJECTABLE;INTRAMUSCULAR

Dosage Strength : EQ 3.75MG BASE/VIAL

Packaging :

Approval Date : 2000-06-15

Application Number : 20715

Regulatory Info : RX

Registration Country : USA

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

AZURITY

U.S.A
EPS
Not Confirmed
arrow

AZURITY

U.S.A
arrow
EPS
Not Confirmed

TRIPTORELIN PAMOATE

Brand Name : TRIPTODUR KIT

Dosage Form : FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

Dosage Strength : EQ 22.5MG BASE/VIAL

Approval Date : 2017-06-29

Application Number : 208956

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

02

VERITY

Canada
EPS
Not Confirmed
arrow

VERITY

Canada
arrow
EPS
Not Confirmed

TRIPTORELIN PAMOATE

Brand Name : TRELSTAR

Dosage Form : INJECTABLE;INTRAMUSCULAR

Dosage Strength : EQ 3.75MG BASE/VIAL

Approval Date : 2000-06-15

Application Number : 20715

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

03

VERITY

Canada
EPS
Not Confirmed
arrow

VERITY

Canada
arrow
EPS
Not Confirmed

TRIPTORELIN PAMOATE

Brand Name : TRELSTAR

Dosage Form : INJECTABLE;INTRAMUSCULAR

Dosage Strength : EQ 11.25MG BASE/VIAL

Approval Date : 2001-06-29

Application Number : 21288

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

04

VERITY

Canada
EPS
Not Confirmed
arrow

VERITY

Canada
arrow
EPS
Not Confirmed

TRIPTORELIN PAMOATE

Brand Name : TRELSTAR

Dosage Form : INJECTABLE;INTRAMUSCULAR

Dosage Strength : EQ 22.5MG BASE/VIAL

Approval Date : 2010-03-10

Application Number : 22437

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

Pharmex
Not Confirmed
arrow
arrow
Pharmex
Not Confirmed

Triptorelinum

Brand Name : Pamorelin LA

Dosage Form : Trockensub

Dosage Strength : 3.75mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

02

Pharmex
Not Confirmed
arrow
arrow
Pharmex
Not Confirmed

Triptorelinum

Brand Name : Pamorelin LA

Dosage Form : Trockensub

Dosage Strength : 22.5mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

Pharmex
Not Confirmed
arrow
arrow
Pharmex
Not Confirmed

Triptorelinum

Brand Name : Salvacyl

Dosage Form : Trockensub

Dosage Strength : 11.25mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

04

FERRING SpA

Switzerland
Pharmex
Not Confirmed
arrow

FERRING SpA

Switzerland
arrow
Pharmex
Not Confirmed

Triptorelin

Brand Name : Gonapeptyl Depot

Dosage Form : Tryptoreline 3,75Mg 1 Unit Parenteral Use

Dosage Strength : 1 syringe IM SC 3.75 mg + 1 ampoule solv 1 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

05

Pharmex
Not Confirmed
arrow
arrow
Pharmex
Not Confirmed

Triptorelin

Brand Name : Gonapeptyl

Dosage Form : Injection fluid, resolution

Dosage Strength : 0.1 mg/ml

Packaging : Finish filled syringe

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

06

IPSEN SpA

France
Pharmex
Not Confirmed
arrow

IPSEN SpA

France
arrow
Pharmex
Not Confirmed

Triptorelin

Brand Name : Decapeptyl

Dosage Form : Tryptoreline 11,25Mg 1 Unit Parenteral Use

Dosage Strength : 1 vial IM 11.25 mg + 1 ampoule solv 2 ml + 1 syringe

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

IPSEN SpA

France
Pharmex
Not Confirmed
arrow

IPSEN SpA

France
arrow
Pharmex
Not Confirmed

Triptorelin

Brand Name : Decapeptyl

Dosage Form :

Dosage Strength : 7 Vials 0.1 Mg + 7 Vials Solv  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

Institute Produits Synthèse

Country
Pharmex
Not Confirmed
arrow

Institute Produits Synthèse

Country
arrow
Pharmex
Not Confirmed

triptorelinembonat

Brand Name : Pamorelin

Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Dosage Strength : 11.25 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

09

Institute Produits Synthèse

Country
Pharmex
Not Confirmed
arrow

Institute Produits Synthèse

Country
arrow
Pharmex
Not Confirmed

triptorelinembonat

Brand Name : Pamorelin

Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Dosage Strength : 22.5 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

10

Institut Produits Synthèse (IPSEN) AB

Country
Pharmex
Not Confirmed
arrow

Institut Produits Synthèse (IPSEN) AB

Country
arrow
Pharmex
Not Confirmed

Triptorelin

Brand Name : Pamorelin

Dosage Form : Powder and liquid to depot injection fluid, suspension

Dosage Strength : 22.5 mg

Packaging : Set

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

read-more
read-more

01

Pluviaendo

Turkey
Pharmex
Not Confirmed
arrow

Pluviaendo

Turkey
arrow
Pharmex
Not Confirmed

Triptorelin Pamoate

Brand Name :

Dosage Form : Pre-Filled Syringe

Dosage Strength : 11.25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

01

Pluviaendo

Turkey
Pharmex
Not Confirmed
arrow

Pluviaendo

Turkey
arrow
Pharmex
Not Confirmed

Triptorelin Pamoate

Dosage : Pre-Filled Syringe

Dosage Strength : 11.25MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Turkey

blank

02

Pharmex
Not Confirmed
arrow
arrow
Pharmex
Not Confirmed

Triptorelin

Brand Name : Microrelin

Dosage Form : Injection

Dosage Strength : 3.75MG/2ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Iran

blank

02

Pharmex
Not Confirmed
arrow
arrow
Pharmex
Not Confirmed

Triptorelin

Dosage : Injection

Dosage Strength : 3.75MG/2ML

Brand Name : Microrelin

Approval Date :

Application Number :

Registration Country : Iran

blank

03

Pharmex
Not Confirmed
arrow
arrow
Pharmex
Not Confirmed

Triptorelin

Brand Name :

Dosage Form : Injection

Dosage Strength : 11.25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Iran

blank

03

Pharmex
Not Confirmed
arrow
arrow
Pharmex
Not Confirmed

Triptorelin

Dosage : Injection

Dosage Strength : 11.25MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Iran

blank

04

Pharmex
Not Confirmed
arrow
arrow
Pharmex
Not Confirmed

Triptorelin

Brand Name :

Dosage Form : Injection

Dosage Strength : 22.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Iran

blank

04

Pharmex
Not Confirmed
arrow
arrow
Pharmex
Not Confirmed

Triptorelin

Dosage : Injection

Dosage Strength : 22.5MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Iran

blank

05

Pharmex
Not Confirmed
arrow
arrow
Pharmex
Not Confirmed

Triptorelin

Brand Name :

Dosage Form : Injection

Dosage Strength :

Packaging : Three Months Depot

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

blank

05

Pharmex
Not Confirmed
arrow
arrow
Pharmex
Not Confirmed

Triptorelin

Dosage : Injection

Dosage Strength :

Brand Name :

Approval Date :

Application Number :

Registration Country : Iran

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - INJECTABLE;INTRAMUSCULAR - EQ 3.75MG...DOSAGE - INJECTABLE;INTRAMUSCULAR - EQ 3.75MG BASE/VIAL

USFDA APPLICATION NUMBER - 20715

read-more

DOSAGE - INJECTABLE;INTRAMUSCULAR - EQ 11.25M...DOSAGE - INJECTABLE;INTRAMUSCULAR - EQ 11.25MG BASE/VIAL

USFDA APPLICATION NUMBER - 21288

read-more

DOSAGE - INJECTABLE;INTRAMUSCULAR - EQ 22.5MG...DOSAGE - INJECTABLE;INTRAMUSCULAR - EQ 22.5MG BASE/VIAL

USFDA APPLICATION NUMBER - 22437

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Grade : Oral

Category : Fillers, Diluents & Binders, Taste Masking

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFaran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

Grade : Oral

Category : Co-Processed Excipients

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

Category : Fillers, Diluents & Binders

05

Pfanstiehl

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

click full view

Solubilizers

read-more
read-more
click full view

Direct Compression

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Taste Masking

read-more
read-more

Parenteral

read-more
read-more

Co-Processed Excipients

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Rheology Modifiers

read-more
read-more

Topical

read-more
read-more

Emulsifying Agents

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Granulation

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Coating Systems & Additives

read-more
read-more

API Stability Enhancers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

read-more
read-more

01

arrow
EPS
Not Confirmed
arrow
EPS
Not Confirmed

Company : Verity Pharmace

Triptorelin Pamoate

Drug Cost (USD) : 14,231,107

Year : 2023

Prescribers : 2074

Prescriptions : 5660

blank

02

arrow
EPS
Not Confirmed
arrow
EPS
Not Confirmed

Company : Allergan/Verity

Triptorelin Pamoate

Drug Cost (USD) : 355,893

Year : 2022

Prescribers : 119

Prescriptions : 134

blank

03

arrow
EPS
Not Confirmed
arrow
EPS
Not Confirmed

Company : Verity Pharmace

Triptorelin Pamoate

Drug Cost (USD) : 14,688,634

Year : 2022

Prescribers : 2266

Prescriptions : 6291

blank

04

arrow
EPS
Not Confirmed
arrow
EPS
Not Confirmed

Company : Allergan/Verity

Triptorelin Pamoate

Drug Cost (USD) : 2,450,188

Year : 2021

Prescribers : 574

Prescriptions : 1055

blank

05

arrow
EPS
Not Confirmed
arrow
EPS
Not Confirmed

Company : Verity Pharmace

Triptorelin Pamoate

Drug Cost (USD) : 10,920,256

Year : 2021

Prescribers : 1753

Prescriptions : 4538

blank

06

arrow
EPS
Not Confirmed
arrow
EPS
Not Confirmed

Company : Allergan/Verity

Triptorelin Pamoate

Drug Cost (USD) : 10,699,121

Year : 2020

Prescribers : 1955

Prescriptions : 4578

blank

07

arrow
EPS
Not Confirmed
arrow
EPS
Not Confirmed

Company : Allergan Inc.

Triptorelin Pamoate

Drug Cost (USD) : 9,803,246

Year : 2019

Prescribers : 1601

Prescriptions : 4298

blank

08

arrow
EPS
Not Confirmed
arrow
EPS
Not Confirmed

Company : Actavis/Allerga

Triptorelin Pamoate

Drug Cost (USD) : 805,253

Year : 2018

Prescribers : 191

Prescriptions : 349

blank

09

arrow
EPS
Not Confirmed
arrow
EPS
Not Confirmed

Company : Allergan Inc.

Triptorelin Pamoate

Drug Cost (USD) : 9,426,445

Year : 2018

Prescribers : 1575

Prescriptions : 4151

blank

10

arrow
EPS
Not Confirmed
arrow
EPS
Not Confirmed

Company : Actavis/Allerga

Triptorelin Pamoate

Drug Cost (USD) : 5,828,535

Year : 2017

Prescribers : 1405

Prescriptions : 2474

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Regulatory FDF Prices

read-more
read-more

01

Brand Name : Decapeptyl

France
arrow
EPS
Not Confirmed

Brand Name : Decapeptyl

France
arrow
EPS
Not Confirmed

Triptorelin Pamoate

Dosage Form :

Dosage Strength : 7 Vials 0.1 Mg + 7 Vials Solv  

Price Per Pack (Euro) : 44.78

Published in :

Country : Italy

RX/OTC/DISCN : Class C

blank

02

Brand Name : Decapeptyl

Switzerland
arrow
EPS
Not Confirmed

Brand Name : Decapeptyl

Switzerland
arrow
EPS
Not Confirmed

Triptorelin Pamoate

Dosage Form : Inj L?s

Dosage Strength : 0.1mg/ml

Price Per Pack (Euro) : 45.38

Published in :

Country : Switzerland

RX/OTC/DISCN : Class A

blank

03

Brand Name : Gonapeptyl

Switzerland
arrow
EPS
Not Confirmed

Brand Name : Gonapeptyl

Switzerland
arrow
EPS
Not Confirmed

Triptorelin Pamoate

Dosage Form : Injection fluid, resolution

Dosage Strength : 0.1 mg/ml

Price Per Pack (Euro) : 47.531

Published in :

Country : Norway

RX/OTC/DISCN :

blank

04

Brand Name : Pamorelin LA

Switzerland
arrow
EPS
Not Confirmed

Brand Name : Pamorelin LA

Switzerland
arrow
EPS
Not Confirmed

Triptorelin Pamoate

Dosage Form : Trockensub

Dosage Strength : 11.25mg

Price Per Pack (Euro) : 320.02

Published in :

Country : Switzerland

RX/OTC/DISCN : Class A

blank

05

Brand Name : Pamorelin LA

Switzerland
arrow
EPS
Not Confirmed

Brand Name : Pamorelin LA

Switzerland
arrow
EPS
Not Confirmed

Triptorelin Pamoate

Dosage Form : Trockensub

Dosage Strength : 3.75mg

Price Per Pack (Euro) : 110.49

Published in :

Country : Switzerland

RX/OTC/DISCN : Class A

blank

06

Brand Name : Pamorelin LA

Switzerland
arrow
EPS
Not Confirmed

Brand Name : Pamorelin LA

Switzerland
arrow
EPS
Not Confirmed

Triptorelin Pamoate

Dosage Form : Trockensub

Dosage Strength : 22.5mg

Price Per Pack (Euro) : 589.5

Published in :

Country : Switzerland

RX/OTC/DISCN : Class A

blank

07

Brand Name : Salvacyl

Switzerland
arrow
EPS
Not Confirmed

Brand Name : Salvacyl

Switzerland
arrow
EPS
Not Confirmed

Triptorelin Pamoate

Dosage Form : Trockensub

Dosage Strength : 11.25mg

Price Per Pack (Euro) : 292.07

Published in :

Country : Switzerland

RX/OTC/DISCN : Class B

blank

08

Brand Name : Pamorelin

Country
arrow
EPS
Not Confirmed

Brand Name : Pamorelin

Country
arrow
EPS
Not Confirmed

Triptorelin Pamoate

Dosage Form : Powder and liquid to depot injec...

Dosage Strength : 11.25 mg

Price Per Pack (Euro) : 311.81

Published in :

Country : Norway

RX/OTC/DISCN :

blank

09

Brand Name : Pamorelin

Country
arrow
EPS
Not Confirmed

Brand Name : Pamorelin

Country
arrow
EPS
Not Confirmed

Triptorelin Pamoate

Dosage Form : Powder and liquid to depot injec...

Dosage Strength : 22.5 mg

Price Per Pack (Euro) : 637.42

Published in :

Country : Norway

RX/OTC/DISCN :

blank

10

Brand Name : Pamorelin

Country
arrow
EPS
Not Confirmed

Brand Name : Pamorelin

Country
arrow
EPS
Not Confirmed

Triptorelin Pamoate

Dosage Form : Powder and liquid to depot injec...

Dosage Strength : 3.75 mg

Price Per Pack (Euro) : 123.49

Published in :

Country : Norway

RX/OTC/DISCN :

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Annual Reports

read-more
read-more

01

Brand Name : Decapeptyl

Triptorelin

arrow
EPS
Not Confirmed

Brand Name : Decapeptyl

France
arrow
EPS
Not Confirmed

Triptorelin

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 472

2019 Revenue in Millions : 493

Growth (%) : -4

blank

02

Brand Name : Decapeptyl

Triptorelin

arrow
EPS
Not Confirmed

Brand Name : Decapeptyl

France
arrow
EPS
Not Confirmed

Triptorelin

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 506

2020 Revenue in Millions : 472

Growth (%) : 18

blank

03

Brand Name : Decapeptyl

Triptorelin

arrow
EPS
Not Confirmed

Brand Name : Decapeptyl

France
arrow
EPS
Not Confirmed

Triptorelin

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 568

2021 Revenue in Millions : 506

Growth (%) : 12

blank

04

Brand Name : Decapeptyl

Triptorelin

arrow
EPS
Not Confirmed

Brand Name : Decapeptyl

France
arrow
EPS
Not Confirmed

Triptorelin

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 589

2022 Revenue in Millions : 568

Growth (%) : 3

blank

05

Brand Name : Decapeptyl

Triptorelin

arrow
EPS
Not Confirmed

Brand Name : Decapeptyl

France
arrow
EPS
Not Confirmed

Triptorelin

Main Therapeutic Indication : Oncology

Currency : USD

2024 Revenue in Millions : 556

2023 Revenue in Millions : 589

Growth (%) : -6

blank

06

Brand Name : Decapeptyl

Triptorelin

arrow
EPS
Not Confirmed

Brand Name : Decapeptyl

France
arrow
EPS
Not Confirmed

Triptorelin

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2015 Revenue in Millions : 349

2014 Revenue in Millions : 367

Growth (%) : 5%

blank

07

Brand Name : Decapeptyl

Triptorelin

arrow
EPS
Not Confirmed

Brand Name : Decapeptyl

France
arrow
EPS
Not Confirmed

Triptorelin

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2016 Revenue in Millions : 360

2015 Revenue in Millions : 354

Growth (%) : 2

blank

08

Brand Name : Decapeptyl

Triptorelin

arrow
EPS
Not Confirmed

Brand Name : Decapeptyl

France
arrow
EPS
Not Confirmed

Triptorelin

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2017 Revenue in Millions : 432

2016 Revenue in Millions : 421

Growth (%) : 3

blank

09

Brand Name : Decapeptyl

Triptorelin

arrow
EPS
Not Confirmed

Brand Name : Decapeptyl

France
arrow
EPS
Not Confirmed

Triptorelin

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2018 Revenue in Millions : 421

2017 Revenue in Millions : 394

Growth (%) : 7%

blank

10

Brand Name : Decapeptyl

Triptorelin

arrow
EPS
Not Confirmed

Brand Name : Decapeptyl

France
arrow
EPS
Not Confirmed

Triptorelin

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2014 Revenue in Millions : 7%

2013 Revenue in Millions :

Growth (%) :

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
EPS
Not Confirmed

AZURITY

U.S.A
arrow
EPS
Not Confirmed

TRIPTORELIN PAMOATE

US Patent Number : 10166181

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208956

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-06-30

blank

02

arrow
EPS
Not Confirmed

VERITY

Canada
arrow
EPS
Not Confirmed

TRIPTORELIN PAMOATE

US Patent Number : 10166181

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22437

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-06-30

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 57773-63-4 / Triptorelin Pamoate API manufacturers, exporters & distributors?

Triptorelin Pamoate manufacturers, exporters & distributors 1

93

PharmaCompass offers a list of Triptorelin Pamoate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Triptorelin Pamoate manufacturer or Triptorelin Pamoate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Triptorelin Pamoate manufacturer or Triptorelin Pamoate supplier.

PharmaCompass also assists you with knowing the Triptorelin Pamoate API Price utilized in the formulation of products. Triptorelin Pamoate API Price is not always fixed or binding as the Triptorelin Pamoate Price is obtained through a variety of data sources. The Triptorelin Pamoate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Triptorelin Pamoate

Synonyms

57773-63-4, Triptoreline, Arvekap, (d-trp6)-gnrh, Decapeptyl, Triptorelina

Cas Number

57773-63-4

About Triptorelin Pamoate

A potent synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE with D-tryptophan substitution at residue 6.

Triptorelin Pamoate Manufacturers

A Triptorelin Pamoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Triptorelin Pamoate, including repackagers and relabelers. The FDA regulates Triptorelin Pamoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Triptorelin Pamoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Triptorelin Pamoate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Triptorelin Pamoate Suppliers

A Triptorelin Pamoate supplier is an individual or a company that provides Triptorelin Pamoate active pharmaceutical ingredient (API) or Triptorelin Pamoate finished formulations upon request. The Triptorelin Pamoate suppliers may include Triptorelin Pamoate API manufacturers, exporters, distributors and traders.

click here to find a list of Triptorelin Pamoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Triptorelin Pamoate USDMF

A Triptorelin Pamoate DMF (Drug Master File) is a document detailing the whole manufacturing process of Triptorelin Pamoate active pharmaceutical ingredient (API) in detail. Different forms of Triptorelin Pamoate DMFs exist exist since differing nations have different regulations, such as Triptorelin Pamoate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Triptorelin Pamoate DMF submitted to regulatory agencies in the US is known as a USDMF. Triptorelin Pamoate USDMF includes data on Triptorelin Pamoate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Triptorelin Pamoate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Triptorelin Pamoate suppliers with USDMF on PharmaCompass.

Triptorelin Pamoate WC

A Triptorelin Pamoate written confirmation (Triptorelin Pamoate WC) is an official document issued by a regulatory agency to a Triptorelin Pamoate manufacturer, verifying that the manufacturing facility of a Triptorelin Pamoate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Triptorelin Pamoate APIs or Triptorelin Pamoate finished pharmaceutical products to another nation, regulatory agencies frequently require a Triptorelin Pamoate WC (written confirmation) as part of the regulatory process.

click here to find a list of Triptorelin Pamoate suppliers with Written Confirmation (WC) on PharmaCompass.

Triptorelin Pamoate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Triptorelin Pamoate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Triptorelin Pamoate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Triptorelin Pamoate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Triptorelin Pamoate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Triptorelin Pamoate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Triptorelin Pamoate suppliers with NDC on PharmaCompass.

Triptorelin Pamoate GMP

Triptorelin Pamoate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Triptorelin Pamoate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Triptorelin Pamoate GMP manufacturer or Triptorelin Pamoate GMP API supplier for your needs.

Triptorelin Pamoate CoA

A Triptorelin Pamoate CoA (Certificate of Analysis) is a formal document that attests to Triptorelin Pamoate's compliance with Triptorelin Pamoate specifications and serves as a tool for batch-level quality control.

Triptorelin Pamoate CoA mostly includes findings from lab analyses of a specific batch. For each Triptorelin Pamoate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Triptorelin Pamoate may be tested according to a variety of international standards, such as European Pharmacopoeia (Triptorelin Pamoate EP), Triptorelin Pamoate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Triptorelin Pamoate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty